Michael A. Pereira is a seasoned regulatory and quality executive with over three decades of experience guiding companies through the complex intersection of FDA compliance, global regulatory standards, and business operations. Known for his ability to build and remediate Quality Management Systems across diverse healthcare sectors—including drug, device, biologic, and combination products—Michael has led strategic initiatives for startups and global enterprises alike. With a rare ability to bridge technical and business teams, he brings clarity, structure, and strategic foresight to every challenge, earning a reputation as a trusted leader and advisor in highly regulated industries.

Jennifer T. Feldman, MBA, HTL (ASCP), QIHC, is a visionary healthcare business development leader with over 23 years of experience in oncology diagnostics, medical devices, and biotechnology. She has a proven track record of driving strategic partnerships, advancing innovative technologies, and optimizing commercial success in the healthcare industry. Jennifer’s expertise spans clinical pathology, research-use-only applications, and companion diagnostics, making her a key player in transforming patient care. With an MBA in International Business and certifications in histotechnology and immunohistochemistry, she seamlessly blends technical proficiency with business acumen. A sought-after speaker and industry expert, Jennifer is passionate about leveraging her knowledge and leadership to foster innovation, improve healthcare outcomes, and contribute to the future of medical advancements.

Brian Dakin, PMP, CIPM, is a seasoned leader in project management, data privacy, and technology solutions within the life sciences industry. As the Principal of Rhombus Consulting, he has driven strategic initiatives that enhance operational efficiency, regulatory compliance, and data governance for pharmaceutical and biotechnology organizations. In his role as President and Head of Operations for a trusted third-party entity, he has led efforts in patient de-identification, achieving HIPAA and SOC2 Type 2 compliance while increasing revenue and profitability. A thought leader and member of the Forbes Coaches Council, Brian also developed **On The Ball Theory**, a framework designed to help individuals unlock their potential and achieve meaningful personal and professional goals. His extensive experience, combined with his commitment to innovation and mentorship, has positioned him as an influential figure in both corporate leadership and personal development.

Excited to share my professional biography, highlighting my journey in the medical device industry, my expertise in quality systems and regulatory compliance, and my passion for driving innovation in healthcare technology. With over a decade of experience, I continue to focus on advancing medical devices through strategic quality initiatives and global regulatory alignment.

I’m excited to share my executive biography, highlighting my experience in R&D, regulatory strategy, and product innovation within the medical device industry. As I transition into board and advisory roles, I look forward to leveraging my expertise to help med-tech companies scale, innovate, and navigate regulatory landscapes.

Excited to share my professional executive biography! With over 20 years of experience in biotech program management, drug development, and regulatory strategy, I have had the privilege of leading cross-functional teams, guiding early-stage startups, and ensuring successful clinical execution. If you're looking for strategic leadership, operational excellence, and industry expertise, I’d love to connect and explore opportunities to collaborate.

Raymond Chang is a seasoned Translational Imaging Scientist with over two decades of experience spanning pharmaceutical research, contract research organizations, and academic discovery. Renowned for his expertise in advanced imaging modalities such as PET, SPECT, and CT, Chang has contributed significantly to the development of preclinical disease models and innovative therapeutics. His career highlights include leading the enterprise implementation of multimodality bioinformatics systems, developing cutting-edge imaging tools, and managing GLP and Non-GLP studies that bridge preclinical and clinical research. A dedicated leader and collaborator, Chang excels in regulatory compliance, experimental design, and fostering partnerships, making him a pivotal figure in advancing personalized medicine and imaging science.